Phase I trials are needed to identify the maximum safe dose of both inorganic and organic selenium (Se) compounds that could be used under medical supervision for patients at extremely high risk of cancer. Based on naturally occurring episodes of chronic selenosis and experience with Se supplementation trials, we recommend a range of doses for inorganic and organic Se compounds that should be investigated in a Phase I trial in order to identify the maximum tolerated dose for these compounds.
References
1.
1. Combs, G.F. Jr., Clark, L.C. (1985). Can dietary selenium modify cancer risk? Nut. Rev.43, 325–331.
2.
2. Clark, L.C., Graham, G.F., Bray, J., Turnbull, B., Hulka, B., and Shy, C. (1986). Plasma selenium and nonmelanoma skin cancer: A prospective cohort study. In: Proceedings of the Third International Conference on Selenium in Biology and Medicine. G.F. Combs, Jr., J.E. Spollholz, O.A. Levander, and J.E. Oldfield (eds.). Westport, CT: AVI Publishing Co.
3.
3. Salonen, J.T., Alfthan, G., Huttunen, J.K., and Puska, P. (1984). Association between serum selenium and the risk of cancer. Am. J. Epidemiol.120, 342–348.
4.
4. Willett, W., Polk, B.F., Morris, S., Stampfer, M.J., Pressel, S., Rosner, B., Taylor, J.O., Schneider, K., and Hames, C.G. (1983). Prediagnostic serum selenium and risk of cancer. Lancet2, 130–134.
5.
5. Clark, L.C., and Combs, G.F. Jr. (1986). Selenium compounds and the prevention of cancer: Research needs and public health implications. J. Nutr.116(1), 170–173.
6.
6. Lemly, R.E., and Merryman, M.P. (1941). Selenium poisoning in humans. Lancet61, 435–438.
7.
7. Yang, G., Wang, S., Zhour, R., and Sun, S. (1983). Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr.37, 872–881.
8.
8. Yang, G. (1983). The relationship between Se and etiology of Keshan disease. Sheng Li Ko Hsueh Chin Chan14(4), 313–317 (in Chinese).
9.
9. Herdel-Vegas, F. (1966). The depilatory and cytotoxic action of Coco de Mona and its relationship to chronic selenosis. Econ. Bot.20, 187–195.
10.
10. Helzlsour, K. (1985). Selenium intoxications in humans. Presented at the Workshop on Selenium and Cancer, National Cancer Institute, Bethesda, MD, February 7–8, 1985.
11.
11. Jaffe, W.G., Ruphael, D., Mondragon, M.D., and Cuevas, M.A. (1972). Estudio clinico i bioquimico en ninos escolares de una zona selenifera. Arch. Latinam. Nutr.22, 595–611.
12.
12. Chen, X., Yang, G., Chen, J., Chen, X., Wen, Z., and Ge, K. (1980). Studies on the relations of Se and Keshan disease. Biol. Trace Element Res.2, 91–107.
13.
13. Chen, J. (1982). Observations on the effect of sodium selenite in the prevention of Keshan disease. Acta Nutr. Sin.4, 243–249.
14.
14. WEN (1986). Height and weight of children supplemented with sodium selenite for 10 years. In: Proceedings of the Third International Conference on Selenium in Biology and Medicine. G.F. Combs, Jr., J.E. Spollholz, O.A. Levander, and J.E. Oldfield (eds.). Westport, CT: AVI Publishing Co.
15.
15. Qian, J. (1985). Unpublished data. Sanitary and Anti-Epidemic Station of Liangshan Autonomous Prefecture, Sichuan Province, personal communication.
16.
16. Yang, J. (1982). A Clinical Trial of Patients with Coronary Heart Disease Using Sodium Selenite and Vitamin E. Masters Thesis, Institute of Health, China National Center for Preventive Medicine (in Chinese).
